Mark Sullivan, the Chief Legal Officer of $MNMD, sold 11,278 shares of the company on 09-25-2025 for an estimated $110,186. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.7% of their shares of this class of stock. Following this trade, they now own 293,852 shares of this class of $MNMD stock.
$MNMD Insider Trading Activity
$MNMD insiders have traded $MNMD stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $MNMD stock by insiders over the last 6 months:
- ROBERT BARROW (Chief Executive Officer) has made 0 purchases and 2 sales selling 52,288 shares for an estimated $432,175.
- MARK SULLIVAN (Chief Legal Officer) has made 0 purchases and 2 sales selling 22,769 shares for an estimated $188,324.
- DANIEL KARLIN (Chief Medical Officer) has made 0 purchases and 2 sales selling 15,552 shares for an estimated $128,634.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MNMD Hedge Fund Activity
We have seen 71 institutional investors add shares of $MNMD stock to their portfolio, and 96 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OCTAGON CAPITAL ADVISORS LP removed 16,220,000 shares (-88.4%) from their portfolio in Q2 2025, for an estimated $105,267,800
- MARSHALL WACE, LLP added 828,067 shares (+31.9%) to their portfolio in Q2 2025, for an estimated $5,374,154
- TRI LOCUM PARTNERS LP removed 820,793 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $4,801,639
- WOODLINE PARTNERS LP removed 503,000 shares (-50.0%) from their portfolio in Q2 2025, for an estimated $3,264,470
- UBS GROUP AG added 406,419 shares (+376.2%) to their portfolio in Q2 2025, for an estimated $2,637,659
- ALLY BRIDGE GROUP (NY) LLC added 336,029 shares (+86.1%) to their portfolio in Q2 2025, for an estimated $2,180,828
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 258,747 shares (-7.7%) from their portfolio in Q2 2025, for an estimated $1,679,268
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MNMD Analyst Ratings
Wall Street analysts have issued reports on $MNMD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Chardan Capital issued a "Buy" rating on 08/01/2025
To track analyst ratings and price targets for $MNMD, check out Quiver Quantitative's $MNMD forecast page.
$MNMD Price Targets
Multiple analysts have issued price targets for $MNMD recently. We have seen 2 analysts offer price targets for $MNMD in the last 6 months, with a median target of $22.5.
Here are some recent targets:
- Jay Olson from Oppenheimer set a target price of $25.0 on 08/04/2025
- Rudy Li from Chardan Capital set a target price of $20.0 on 08/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
